Published On: Fri, Sep 16th, 2016

Stock Analysts’ Updated EPS Estimates for September, 16th (ABMD, ACA, AERI, BATRA, CLI, CRTO, DBK, DXCM, EGN, EKSO)

Stock Analysts’ updated eps estimates for Friday, September 16th:
Abiomed (NASDAQ:ABMD) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $138.00 target price on the stock. According to Zacks, “Abiomed’s Impella utilization is accelerating at a remarkable pace with an increasing number of hospitals and customer sites purchasing the same. We believe that flagship Impella product line is a significant growth catalyst for the company. The company reported impressive first quarter 2017 results beating the Zacks Consensus Estimate on both lines. The revenue guidance was also positive, which will drive the stock price in the near term. The expanding product pipeline and continuing investments on capacity expansion are key growth catalysts. Anticipated regulatory approval in Japan is also growth driver, in our view. However, intensifying competition may hurt pricing power going forward.”
Acacia Mining PLC (LON:ACA) was downgraded by analysts at Panmure Gordon to a hold rating. Panmure Gordon currently has GBX 400 ($5.33) target price on the stock.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/16/stock-analysts-updated-eps-estimates-for-september-16th-abmd-aca-aeri-batra-cli-crto-dbk-dxcm-egn-ekso.html

Aerie Pharmaceuticals (NASDAQ:AERI) had its outperform rating reissued by analysts at RBC Capital Markets. RBC Capital Markets currently has a $55.00 price target on the stock, up from their previous price target of $51.00.
Gabelli started coverage on shares of Liberty Braves Group (NASDAQ:BATRA). They issued a buy rating and a $29.00 price target on the stock.
Mack-Cali Realty Corp. (NYSE:CLI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $30.00 target price on the stock. According to Zacks, “Mack-Cali is making solid strides in its 20/15 strategic plan. Laid down last year, this plan is aimed at transforming Mack-Cali by focusing on waterfront and transit-based office holdings in the Northeast, and on luxury multi-family portfolio growth. It also includes planned exits from non-core markets and capital improvements in core assets. For office portfolio, the company is targeting an increased leased percentage to 90% by the end of 2016 and 93% in 2017. Also, it plans to lower expenses in office operations and reduce credit costs through refinancing options in 2016 and 2017. Such transformations and diversification into the apartment sector are expected to drive growth and improve cash flow. Its funds from operations (FFO) per share estimates have also been moving up lately. Yet, earnings-dilutive effects of disposition and any rise in interest rate are potential headwinds.”
Criteo SA (NASDAQ:CRTO) had its buy rating reiterated by analysts at Jefferies Group. The firm currently has a $63.00 price target on the stock.
Deutsche Bank AG (FRA:DBK) was given a €11.00 ($12.22) target price by analysts at Bank of America Corp.. The firm currently has a a sell rating on the stock.
BMO Capital Markets started coverage on shares of DexCom (NASDAQ:DXCM). They issued an outperform rating on the stock.
Energen Corp. (NYSE:EGN) was upgraded by analysts at Tudor Pickering from a hold rating to a buy rating.
B. Riley initiated coverage on shares of Ekso Bionics Holdings (OTC:EKSO). The firm issued a buy rating and a $8.00 price target on the stock.
First Hawaiian (NYSE:FHB) had its buy rating reiterated by analysts at Barclays PLC.
Hutchison China MediTech Limited (LON:HCM) had its buy rating reaffirmed by analysts at Panmure Gordon. The firm currently has a GBX 2,630 ($35.03) price target on the stock.
Intercept Pharmaceuticals (NASDAQ:ICPT) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $239.00 price target on the stock.
Integrated Device Technology (NASDAQ:IDTI) had its buy rating reissued by analysts at Needham & Company LLC.
Sanford C. Bernstein began coverage on shares of Tyco International (NYSE:JCI). Sanford C. Bernstein issued an outperform rating on the stock.
Gabelli began coverage on shares of K2M Group Holdings (NASDAQ:KTWO). Gabelli issued a buy rating and a $22.00 target price on the stock.
New Jersey Resources Corp. (NYSE:NJR) had its buy rating reissued by analysts at Argus.
Nike (NYSE:NKE) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Nike’s customer-centric approach, innovative products and strong portfolio has helped strengthened its position in the footwear and athletic apparel industry. The company also continues to seek opportunities for increasing its market share via acquisitions, contracts to supply sports-related assortments, and development of its eCommerce and DTC business model. Nike’s strategic initiatives are well reflected from its positive earnings surprise streak over the past 16 straight quarters. However, top line has been missing estimates for quite some time due to adverse currency movements. Evidently, the company expects lingering currency woes to strongly hurt revenues in first-half fiscal 2017. Also, the company’s future orders witnessed a considerable slowdown and lagged expectations in the fourth quarter due to stiff competition from rivals. Estimates have been stable ahead of the company’s first-quarter earnings release.”
Oracle Corp. (NYSE:ORCL) had its target price increased by Nomura from $44.00 to $45.00. Nomura currently has a buy rating on the stock.
Oracle Corp. (NYSE:ORCL) had its price target cut by RBC Capital Markets from $43.00 to $42.00. They currently have an outperform rating on the stock.
Resolute Energy Corp. (NYSE:REN) had its hold rating reaffirmed by analysts at Barclays PLC. They currently have a $25.00 target price on the stock. The analysts wrote, “We are raising our estimates and price target in response to REN’s recent strategic shift to the Delaware Basin (Permian). Results from the company’s Wolfcamp A drilling program have been strong, and have substantially repositioned the company’s growth profile and financial position. As a result, we are increasing our 2017 and 2018 production forecast to 17.24 Mboe/d (from 16.06 Mboe/d) and to 20.00 Mboe/d (from 16.92 Mboe/d), respectively. We are increasing our 2017 and 2018 CAPEX forecasts to $205 million (from $155 million) and to $250 million (from $200 million). As a result, we are increasing our price target to $25/sh, up from $8.00 /sh.””
Rigel Pharmaceuticals (NASDAQ:RIGL) had its positive rating reiterated by analysts at Jefferies Group. Jefferies Group currently has a $9.00 target price on the stock, up from their previous target price of $8.50.
Scancell Holdings Plc (LON:SCLP) had its buy rating reissued by analysts at Panmure Gordon. They currently have a GBX 68 ($0.91) price target on the stock.
JMP Securities began coverage on shares of SVB Financial Group (NASDAQ:SIVB). The firm issued an outperform rating on the stock.
Inventure Foods (NASDAQ:SNAK) had its price target increased by DA Davidson from $10.00 to $11.00. They currently have a buy rating on the stock.
Shutterstock (NYSE:SSTK) had its price target increased by Jefferies Group from $60.00 to $62.00. They currently have a hold rating on the stock.
Constellation Brands (NYSE:STZ) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $186.00 target price on the stock. According to Zacks, “Constellation Brands boasts a portfolio of well-known brands and is the largest wine company in the world, which gives it a competitive edge and bolsters its solid market position. The company’s focus on brand building and efforts to include new products in its wine and spirits portfolio are key growth drivers. Also, it remains committed to expanding operations directed toward achieving business growth, as is evident from its numerous acquisitions. These factors, coupled with strong beer business also helped the company to post its seventh straight earnings beat in the last reported quarter. However, the risk of increasing taxes continues to be a concern for the company. Intense competition, currency fluctuations and seasonal nature of the company’s business can also dent its operating performance. Nonetheless, estimates have been largely stable going into the second quarter earnings release.”
Telefonica SA (NYSE:TEF) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Telefonica’s continued focus on organic growth and portfolio optimization should serve it well over the long term. The company is poised to benefit from the widespread adoption of broadband and data services, pricing revision, network enhancement and strategic collaborations.  Moreover, the company’s strong presence in the Mexican wireless industry should reap substantial benefits going forward. Also, a sucessful IPO of its of its infrastructure division Telxius should boost its balance sheet by cutting significant amount of debt. Notably, the company has a debt laden balance sheet which may pose problems going ahead. Moreover, domestic competition poses a major headwind.”
Credit Suisse Group AG started coverage on shares of Target Corp. (NYSE:TGT). They issued a neutral rating on the stock.
WEC Energy Group (NYSE:WEC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “WEC Energy Group depends on coal to produce a major portion of its electricity. No doubt the company is working to comply with stringent environment regulation. However, installation of low-emission infrastructure at its generation systems to meet regulatory compliance will increase its cost of operations. Further, the company is subject to operational risks associated with the breakdown or failure of equipment or processes due to fuel supply or transportation disruptions, accidents and labor disputes or work stoppages by employees. However, WEC Energy Group’s investments in infrastructure projects will help it to meet increasing customer demand and improve service reliability. WEC Energy Group’s decision to acquire Integrys has been fruitful, adding nearly $620 million to the company’s top line in the second quarter.”

Receive News & Ratings for Abiomed Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Abiomed Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>